You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Lck (phospho Y505) antibody (ab4901)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Lck (phospho Y505) antibody
See all Lck products (18) ...

Description

Rabbit polyclonal to Lck (phospho Y505)

Specificity

Hck [pY522] (75% homology), and Lyn [pY508] (83.3% homology) have not been tested.

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Chicken

Immunogen

Synthetic peptide (Human) derived from the region of Lck that contains tyrosine 505 (based on Swiss Protein database, accession number P06239). The sequence is conserved in human and mouse.

Positive control

Full length untagged recombinant human Lck protein.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.05% Sodium Azide
Constituents: PBS, 1mg/ml BSA (IgG, protease free). pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

Purified from rabbit serum by sequential epitope-specific chromatography. The antibody has been negatively preadsorbed using (i) a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated Lck, and (ii) a generic tyrosine phosphorylated peptide to remove antibody that is reactive with phospho-tyrosine (irrespective of the sequence). The final product is generated by affinity chromatography using a Lck-derived peptide that is phosphorylated at tyrosine 505.

Primary antibody notes

Lck (p56lck), a member of the Src family of non-receptor tyrosine protein kinases, is expressed predominantly in T cells. Lck function is critical both for T cell development in the thymus and activation of mature T cells in the periphery by antigen. The activity of Lck is regulated by phosphorylation of two conserved tyrosine residues, Tyr-505 (equivalent to Tyr-529 in c-Src) and Tyr-394 (equivalent to Tyr-418 in c-Src). Tyr-505 is located near the carboxyl terminus of Lck and, when phosphorylated, associates intramolecularly with the SH2 domain in the amino-terminal half of the protein. This helps stabilise Lck in a conformation that, biologically, is relatively inactive. In the absence of phosphorylation at Tyr-505, intramolecular binding of the carboxyl terminus to the SH2 domain does not occur, and Lck exhibits increased activity in vivo.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Anti-Lck (phospho Y505) antibody (ab4901)Western blot - Anti-Lck (phospho Y505) antibody (ab4901) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab4901 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Tyrosine kinase that plays an essential role for the selection and maturation of developing T-cell in the thymus and in mature T-cell function. Is constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors and plays a key role in T-cell antigen receptor(TCR)-linked signal transduction pathways. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, and thereby recruits the associated LCK to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosines residues within the immunoreceptor tyrosines-based activation motifs (ITAMs) in the cytoplasmic tails of the TCRgamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. In addition, contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, and upon engagement of the CD2 molecule, LCK undergoes hyperphosphorylation and activation. Also plays a role in the IL2 receptor-linked signaling pathway that controls T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR. Phosphorylates RUNX3.

Tissue specificity

Expressed specifically in lymphoid cells.

Involvement in disease

Note=A chromosomal aberration involving LCK is found in leukemias. Translocation t(1;7)(p34;q34) with TCRB.

Sequence similarities

Belongs to the protein kinase superfamily. Tyr protein kinase family. SRC subfamily.
Contains 1 protein kinase domain.
Contains 1 SH2 domain.
Contains 1 SH3 domain.

Domain

The SH2 domain mediates interaction with SQSTM1. Interaction is regulated by Ser-59 phosphorylation.

Post-translational
modifications

Phosphorylated on Tyr-394, which increases enzymatic activity (By similarity). Phosphorylated on Tyr-505, which decreases activity.

Cellular localization

Cytoplasm. Cell membrane. Present in lipid rafts in an unactive form.

Target information above from: UniProt accessionP06239 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • LCK antibody
  • Lck p56 antibody
  • LCK_HUMAN antibody
  • Leukocyte C-terminal Src kinase antibody
  • LSK antibody
  • Lymphocyte cell specific protein tyrosine kinase antibody
  • Lymphocyte cell-specific protein-tyrosine kinase antibody
  • Lymphocyte Specific Protein Tyrosine Kinase antibody
  • Membrane associated protein tyrosine kinase antibody
  • Oncogene lck antibody
  • P56 LCK antibody
  • p56(LSTRA) protein tyrosine kinase antibody
  • p56-LCK antibody
  • p56lck antibody
  • pp58 lck antibody
  • pp58lck antibody
  • Protein YT16 antibody
  • Proto oncogene tyrosine protein kinase LCK antibody
  • Proto-oncogene Lck antibody
  • Protooncogene tyrosine protein kinase LCK antibody
  • T cell specific protein tyrosine kinase antibody
  • T cell-specific protein-tyrosine kinase antibody
  • T lymphocyte specific protein tyrosine kinase p56lck antibody
  • Tyrosine-protein kinase Lck antibody
  • YT 16 antibody
  • YT16 antibody
see all

Anti-Lck (phospho Y505) antibody images:

  Western blot - Anti-Lck (phospho Y505) antibody (ab4901)

Western blot - Anti-Lck (phospho Y505) antibody (ab4901)



Predicted band size : 60 kDa


Peptide Competition: Full length untagged recombinant human Lck protein was added to control cell extract which does not contain Lck and then resolved by SDS-PAGE on a 10% Tris-glycine gel. The proteins then were transferred to nitrocellulose and incubated with 0.50 µg/mL ab4901 antibody, following prior incubation with: (1) the appropriately phosphorylated peptide immunogen, (2) the nonphosphorylated peptide corresponding to the peptide immunogen, (3) the non-phosphorylated peptide derived from the corresponding region of Src, (4) a generic phosphotyrosine containing peptide, (5) no peptide, and (6) the phosphorylated peptide derived from the corresponding region of Src. After washing, membranes were incubated with goat F(ab’)2 anti-rabbit IgG alkaline phosphatase conjugate and bands were detected using the Tropix WesternStar detection method. The data presented here demonstrate that only the phosphopeptide corresponding to this site completely blocks the antibody signal, demonstrating the specificity of ab4901 antibody for this phosphorylated residue.

References for Anti-Lck (phospho Y505) antibody (ab4901)

ab4901 has not yet been referenced specifically in any publications.

Publishing research using ab4901? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"